National Cancer Institute; Amended Notice of Meeting
---
identifier: "/us/fr/E9-16894"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "E9-16894"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2009-07-16"
last_updated: "2009-07-16"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-16894"
document_type: "notice"
publication_date: "2009-07-16"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "74 FR 34583"
fr_volume: 74
---
# National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 22, 2009, 8 a.m.to July 23, 2009, 5 p.m., Marriott Bethesda North Hotel & Conference Center, Bethesda, MD which was published in the *Federal Register* on June 11, 2009, 74FR27806.
This notice is amended to change the title from “NCI-ARRA Competitive Revisions-Pre Clinical, Drug Discovery & Imaging” to “NCI-ARRA Competitive Revisions & Grand Opportunity-Pre Clinical, Drug Discovery & Imaging”. The meeting is closed to the public.
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.